Is an Ejection Fraction (EF) of 53% indicative of systolic or diastolic dysfunction?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 29, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

An ejection fraction (EF) of 53% is indicative of preserved systolic function, but may be associated with diastolic dysfunction, which cannot be determined solely by EF measurement. Systolic function refers to the heart's ability to contract and pump blood out to the body, which is directly measured by the ejection fraction. According to the 2022 AHA/ACC/HFSA guideline for the management of heart failure 1, a normal EF range is typically considered to be ≥50%, so 53% falls within normal limits. This means the heart is pumping approximately 53% of the blood volume contained in the left ventricle with each contraction.

Some key points to consider in this context include:

  • The guideline defines heart failure with preserved ejection fraction (HFpEF) as an LVEF ≥50% 1
  • Diastolic dysfunction, on the other hand, relates to problems with the heart's ability to relax and fill with blood between beats, which is not directly measured by the ejection fraction 1
  • Diastolic dysfunction can exist even with a normal EF, and would require additional measurements such as E/A ratio, deceleration time, or tissue Doppler imaging for proper diagnosis
  • The diagnosis of HFpEF can be challenging and requires objective measures of cardiac dysfunction, such as elevated natriuretic peptide levels or noninvasive/invasive hemodynamic measurement 1

It's essential to note that while this EF value is technically normal, it's on the lower end of normal, so regular cardiac follow-up would still be advisable, especially if there are any symptoms or risk factors for heart disease. Furthermore, the trajectory of LVEF over time and the cause of heart failure are crucial in evaluating patients with heart failure 1.

From the Research

EF of 53% Classification

  • An EF of 53% can be classified as systolic dysfunction, as it is below the normal range of 55-70% 2.
  • According to the study by 2, 90% of subjects had an LVEF between 53% and 71%, indicating that an EF of 53% is at the lower end of the normal range.
  • However, it is essential to consider that EF is just one measure of cardiac function, and other factors such as infarct size, end-systolic volume index, and clinical outcomes should also be taken into account 3.

Comparison with Other Studies

  • A study published in 3 found that infarct size was a stronger predictor of outcomes than left ventricular ejection fraction or end-systolic volume index, suggesting that EF alone may not be sufficient to determine the severity of cardiac dysfunction.
  • Another study 4 found that right ventricular ejection fraction <20% was an independent predictor of mortality in older systolic heart failure patients, highlighting the importance of considering multiple measures of cardiac function.

Clinical Implications

  • The classification of an EF of 53% as systolic dysfunction has significant clinical implications, as it may indicate a higher risk of adverse outcomes and require more aggressive treatment 2, 3.
  • However, the management of heart failure with preserved ejection fraction (HFpEF) is complex and requires a comprehensive approach, including the use of novel therapeutic classes such as sodium-glucose cotransporter 2 inhibitors and non-steroidal mineralocorticoid receptor antagonists 5.

Related Questions

What is the recommended treatment for a patient with normal left ventricular function, no evidence of myocardial fibrosis or infiltrative disease, and a mildly reduced right ventricular ejection fraction (RVEF) of 37%?
What is the diagnosis and management plan for a patient with a history of normal myocardial perfusion study, normal ejection fraction (EF) with mild left ventricular hypertrophy (LVH) and impaired relaxation filling pattern, mild aortic valve calcification, and moderate mitral valve calcification, presenting with shortness of breath, 1+ to 2+ pitting edema, and currently taking Furosemide (Lasix) 20 milligrams (mg) daily?
What is the best next step in managing hypertension in a 51-year-old female with hypertension (HTN) and hyperlipidemia (HLD) who is currently taking amlodipine (NORVASC) 5 mg, atorvastatin (LIPITOR) 10 mg, and has recently experienced elevated blood pressure?
What is the next step in managing a 52-year-old female with a strong family history of Coronary Artery Disease (CAD), who experiences chest pain (CP) with exertion, has a negative troponin (trop) level, a negative Holter (holter) monitor, grade 1 diastolic dysfunction on echocardiogram (Echo), negative nuclear imaging, but exhibits electrocardiogram (EKG) changes and chest pain during the stress test on a treadmill?
What is the next step in managing a 52-year-old patient with a history of chest pain, recent cardiac arrest, and hypertension?
What are the oral medication regimens for osteomyelitis (infection of the bone) in the heel?
What is the best treatment for chronic nausea and vomiting in an ovarian cancer patient?
Is felodipine (a calcium channel blocker) associated with peripheral edema (feet swelling)?
What is the treatment algorithm for arterial hypertension?
Have you used boric acid for Candida glabrata in pregnant patients?
What is the cause of recurrent redness in a 6-year-old female with a history of congenital cataract in the right eye?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.